Mayinglong Pharmaceutical Group Co., Ltd.

XSSC:600993 Stock Report

Market Cap: CN¥12.3b

Mayinglong Pharmaceutical Group Future Growth

Future criteria checks 0/6

Mayinglong Pharmaceutical Group is forecast to grow revenue at 12.2% per annum.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth18.5%
Revenue growth rate12.2%
Future return on equity14.0%
Analyst coverage

Low

Last updated14 May 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSSC:600993 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20264,559N/A6296521
12/31/20254,067N/A3544911
12/31/20243,600N/A3503561
3/31/20243,259453497754N/A
12/31/20233,137443356604N/A
9/30/20233,19448114162N/A
6/30/20233,245488270396N/A
3/31/20233,416529286388N/A
12/31/20223,532479267342N/A
9/30/20223,640513600665N/A
6/30/20223,644482547607N/A
3/31/20223,473485522580N/A
12/31/20213,385465532597N/A
9/30/20213,58745781144N/A
6/30/20213,479439-1355N/A
3/31/20213,31742792158N/A
12/31/20202,792419238283N/A
9/30/20202,518396651687N/A
6/30/20202,411378543582N/A
3/31/20202,431336425468N/A
12/31/20192,705360445492N/A
9/30/20192,528349190233N/A
6/30/20192,400290344374N/A
3/31/20192,311241355385N/A
12/31/20182,198176283308N/A
9/30/20182,152205289321N/A
6/30/20182,041248141185N/A
3/31/20181,861302215252N/A
12/31/20171,751320N/A356N/A
9/30/20171,884279N/A314N/A
6/30/20171,937266N/A377N/A
3/31/20172,013257N/A291N/A
12/31/20162,103250N/A240N/A
9/30/20161,924245N/A271N/A
6/30/20161,893238N/A117N/A
3/31/20161,833230N/A211N/A
12/31/20151,784223N/A183N/A
9/30/20151,739207N/A142N/A
6/30/20151,657215N/A197N/A
3/31/20151,642203N/A96N/A
12/31/20141,621201N/A112N/A
9/30/20141,607205N/A119N/A
6/30/20141,623199N/A90N/A
3/31/20141,605188N/A111N/A
12/31/20131,602186N/A130N/A
9/30/20131,584189N/A133N/A
6/30/20131,543179N/A138N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 600993's forecast earnings growth is above the savings rate (2.9%).

Earnings vs Market: Insufficient data to determine if 600993's earnings are forecast to grow faster than the CN market

High Growth Earnings: Insufficient data to determine if 600993's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 600993's revenue (12.2% per year) is forecast to grow slower than the CN market (14% per year).

High Growth Revenue: 600993's revenue (12.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 600993's Return on Equity is forecast to be low in 3 years time (14%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.